ClinicalTrials.Veeva

Menu

What Happens in Vegas: PEP to PrEP Opportunities

H

Huntridge Family Clinic

Status

Unknown

Conditions

Exposure to Human Immunodeficiency Virus (Event)

Treatments

Drug: Currently approved medications

Study type

Observational

Funder types

Other

Identifiers

NCT03775083
HFC018001

Details and patient eligibility

About

Observational study looking at barriers to care for individuals seeking care, Post Exposure Prophylaxis (PEP) after an actual or perceived exposure to HIV. Following PEP treatment subjects will be asked about there intent to transition to Pre-Exposure Prophylaxis (PrEP) and surveyed about barriers to care or perceptions of care

Full description

The primary objective of this study is to assess the rate of engagement in a PEP to PrEP HIV provider network for those patients presenting following a non-occupational HIV exposure.

The development of a referral network and intensive clinical follow up of PEP patients will result in more patients appropriately initiating PEP, being referred to appropriate follow up, and post exposure transition and maintaining on PrEP (if indicated) at completion of the PEP medications.

Enrollment

75 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Actual or perceived non-occupational exposure to HIV, by self report, within 72 hours of enrollment and referred for care
  • able and willing to provide informed consent
  • available for 12 months of post expoure follow-up Southern Nevada Ryan White defined service area

Exclusion criteria

  • HIV+ at time of screeing via 4th genderation (Antibody/Antigen) testing
  • Current PEP and/or PrEP product condrainidications as listed in the medication product insert.

Trial contacts and locations

1

Loading...

Central trial contact

John (Rob) Phoenix, MSN, APRN; Christina Madison, PharmD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems